Nucleoside Reverse Transcriptase Inhibitor (NRTI)

DRUG2 trials

Sponsors

Bristol-Myers Squibb, Boehringer Ingelheim

Conditions

HIVHIV Infections

Phase 2

Exploratory Study of Tipranavir and Ritonavir in Multiple Protease Inhibitor-experienced HIV Patients

CompletedNCT02238314

Boehringer IngelheimHIV Infections

Start: 1999-01-31Updated: 2014-09-12

Phase 4

Effects of Famotidine on the Pharmacokinetics of Atazanavir When Coadministered to Participants With HIV Infection

CompletedNCT01232127

Bristol-Myers SquibbHIV

Start: 2011-02-28End: 2011-06-30Updated: 2012-08-31